A detailed history of Schonfeld Strategic Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 49,335 shares of VTRS stock, worth $611,754. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,335
Previous 35,386 39.42%
Holding current value
$611,754
Previous $376,000 52.13%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $143,953 - $169,201
13,949 Added 39.42%
49,335 $572,000
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $355,629 - $425,339
35,386 New
35,386 $376,000
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $296,829 - $367,229
33,846 Added 299.44%
45,149 $488,000
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $108,395 - $128,289
11,303 New
11,303 $111,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $378,744 - $502,097
-43,434 Reduced 56.98%
32,795 $365,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $549,749 - $721,546
64,829 Added 568.68%
76,229 $649,000
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $3.21 Million - $3.96 Million
-322,426 Reduced 96.59%
11,400 $119,000
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $795,993 - $1.25 Million
81,141 Added 32.11%
333,826 $3.63 Million
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $3.05 Million - $3.71 Million
252,685 New
252,685 $3.42 Million
Q3 2021

Nov 16, 2021

SELL
$13.25 - $15.13 $4.18 Million - $4.77 Million
-315,284 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $129,194 - $160,870
-9,961 Reduced 3.06%
315,284 $4.51 Million
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $4.42 Million - $6.03 Million
325,245 New
325,245 $4.54 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.